Roberta Lanzillo
Papers
1
Total Citations
40
H-Index
1
About
Roberta Lanzillo is a leading clinical researcher whose work sits at the intersection of neurology and digital health, with a primary focus on multiple sclerosis (MS). Her major contributions center on evaluating how digital technologies—including wearable sensors, mobile apps, and remote monitoring platforms—can transform the design and execution of clinical trials for MS. Her highly cited 2021 systematic review, "Digital Technology in Clinical Trials for Multiple Sclerosis" (40 citations), provided a comprehensive analysis of how these tools can overcome longstanding barriers in treatment delivery and disease monitoring. By systematically mapping the landscape of digital endpoints and decentralized trial models, Lanzillo’s work has helped pave the way for more patient-centric, real-world evidence generation in MS research. Her findings are particularly impactful for researchers and clinicians seeking to integrate digital biomarkers into regulatory-grade studies, and her scholarship continues to shape discussions on trial efficiency, data quality, and patient engagement. Through her rigorous synthesis of emerging evidence, Lanzillo has established herself as a key voice in the digital transformation of neuroimmunology.
Research Focus
Key Achievements
Top Papers
- 1